Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 8, 2007, Pages 1011-1017

  Tischendorf, J J W ^a,b   Meier, P N ^a   Schneider, A ^a   Manns, M P ^a   Kruger M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cholangiocarcinoma; Dominant bile duct stenosis; Intraductal ultrasonography; Primary sclerosing cholangitis

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRASONOGRAPHY;

EID: 34447123838     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701206761     Document Type: Article

References (31)

1. Chapman RWG, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of clinical features, cholangiography and hepatic histology. Gut 1980;21:870-7.
2. LaRusso NF, Wiesner RH, Ludwig J, McCarthy RL. Primary sclerosing cholangitis. N Engl J Med 1984;310:899-903.
3. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann C, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710-7.
4. Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factor in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-5.
5. Ponsioen CY, Vrouenraets SME, Prawirodidjo W, Rajaram R, Rauws EAJ, Mulde CJJ, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002;51:562-6.
6. Tischendorf JJW, Meier PN, Straßburg C, Klempnauer J, Hecker H, Manns MP, et al. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2006;41:1227-34.
7. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
8. Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121-7.
9. Abu-Elmagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993;25:1124-5.
10. Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease and cancer in patients undergoing liver transplantation. Surgery 1995;118:615-20.
11. Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996;23:1105-11.
12. MacCarty RL, LaRusso NF, May GR, Bender CE, Wiesner RH, King JE, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances. Radiology 1985;156:43-6.
13. Stiehl A, Rudolph G, Klöters-Plachky P, Sauer P, Walker S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002;36:151-6.
14. Berquist A, Glaumann H, Persson B, Broomé U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998;27:311-6.
15. Ponsioen CY, Vrouenraets SME, van Milligen de Witt AWM, Sturm P, Tascilar M, Offerhaus GJA, et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999;31:305-9.
16. Lindberg B, Arnelo U, Bergquist A, Thörne A, Hjerpe A, Granqvist S, et al. Diagnosis of biliary strictures in conjugation with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 2002;34:909-16.
17. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clinic Proc 1993;68:874-9.
18. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108:865-9.
19. Björnsson E, Kilander A, Olsson R. Ca19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999;19:508-10.
20. Hultcrantz R, Olsson R, Danielsson A, Jarnerot G, Loof L, Ryden BO, et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999;30:669-73.
21. Tamada K, Ueno N, Tomiyama T, Oohashi A, Wada S, Nishizono T, et al. Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. Gastrointest Endosc 1998;47:341-9.
22. Menzel J, Poremba C, Dietl K-H, Domschke W. Preoperative diagnosis of bile-duct strictures. Comparison of intraductal ultrasonography with conventional endosonography. Scand J Gastroenterol 2000;35:77-82.
23. Domagk D, Poremba C, Dietl K-H, Senninger N, Heinecke A, Domschke W, et al. Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study. Gut 2002;51:240-4.
24. Farrell RJ, Agarwal B, Brandwein SL, Underhill J, Chuttani R, Pleskow DK. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures. Gastrointest Endosc 2002;56:681-7.
25. Tamada K, Tomiyama T, Wada S, Ohashi A, Satoh Y, Ido K, et al. Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures. Gut 2002;50:326-31.
26. Vazquez-Sequeiros E, Baron TH, Clain JE, Gostout CJ, Norton ID, Petersen BT, et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 2002;56:372-9.
27. Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-63.
28. Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004;60:721-31.
29. Nimura Y, Kamiya J, Hayakawa N, Shionya S. Cholangioscopic differentiation of biliary stricures and polyps. Endoscopy 1989;21:351-6.
30. Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy 1993;25:76-80.
31. Seo DW, Kim MH, Lee SK, Myung SJ, Jang GH, Ha HK. Usefulness of cholangioscopy in patients with focal stricture of the intrahepatic duct unrelated to intrahepatic stones. Gastrointest Endosc 1999;49:204-9.